Search Within

David R Spriggs

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (51)
  2. Meeting Abstract (20)
  3. Book Section (1)
Groups
  1. Epidemiology and Biostatistics (72)
  2. Biostatistics Service (68)
  3. Department of Medicine (62)
  4. Solid Tumor Oncology Division (62)
  5. Gynecology Disease Management Team (51)
  6. GDMT, Medicine (49)

More Groups

People
  1. Alexia Iasonos (42)
  2. Carol Aghajanian (42)
  3. Paul Sabbatini (36)
  4. Martee Hensley (29)
  5. Venkatraman Seshan (24)
  6. David Hyman (21)

More People

Years
  1. 2022 (1)
  2. 2018 (1)
  3. 2017 (2)
  4. 2016 (4)
  5. 2015 (7)
  6. 2014 (5)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. Gynecologic Oncology (15)
  3. Clinical Cancer Research (8)
  4. International Journal of Gynecological Cancer (5)
  5. Cancer (4)
  6. Cancer Research (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (21)
  2. American Association for Cancer Research (16)
  3. Elsevier Inc. (15)
  4. Lippincott Williams & Wilkins (6)
  5. Wiley Blackwell (4)
  6. Oxford University Press (2)

More Publishers

Results (72)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I/pharmacologic study of UCN-01 in combination with 5-fluorouracil in patients with advanced solid tumors
    Meeting Abstract

    Shah, M. A.; Kortmansky, J.; Kelsen, D. P.; Hseuh, C.; Kaubisch, A.; Spriggs, D.; Gonen, M.; Tong, W.; Endres, S.; Schwartz, G. K.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer
    Journal Article

    Hensley, M. L.; Lebeau, D.; Leon, L. F.; Venkatraman, E.; Waltzman, R.; Sabbatini, P.; Almadrones, L.; Chi, D.; Spriggs, D.
    Gynecologic Oncology (2001)

    Fulltext@MSK | Save
  • Intraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian cancer patients with a positive second look
    Journal Article

    Makhija, S.; Sabbatini, P.; Aghajanian, C.; Venkatraman, E.; Spriggs, D. R.; Barakat, R.
    Gynecologic Oncology (2000)

    Fulltext@MSK | Save
  • Phase II trial of intraperitoneal cisplatin and mitoxantrone in patients with persistent ovarian cancer
    Journal Article

    Husain, A.; Sabbatini, P.; Spriggs, D.; Fennelly, D.; Aghajanian, C.; Barakat, R.; Curtin, J.; Venkatraman, E.; Hoskins, W.; Markman, M.
    Gynecologic Oncology (1999)

    Fulltext@MSK | Save
  • A phase I study of CT-2584 in the treatment of advanced carcinoma
    Meeting Abstract

    Waltzman, R.; Pezzulli, S.; Anderson, K.; Singer, J.; Aghajanian, C.; Sabbatini, P.; Chen, Y.; Ulerio, G.; Goodrich, K.; Venkatraman, E.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (1998)

    Fulltext@MSK | Save
  • BRCA1 upregulation is associated with repair mediated resistance to cisplatin (CDDP) and antisense suppression of BRCA1 increases sensitivity to CDDP, decreases DNA damage repair proficiency and enhances apoptosis
    Meeting Abstract

    Husain, A.; He, G.; Venkatraman, E. S.; Spriggs, D. R.
    Proceedings of the American Association for Cancer Research Annual Meeting (1998)

    Fulltext@MSK | Save
  • Targeted therapy in ovarian, fallopian tube, and peritoneal cancer: A phase I study of vaccination with the Lewis Y-KLH conjugate and QS-21
    Meeting Abstract

    Sabbatini, P.; Livingston, P.; Lloyd, K.; Aghajanian, C.; Spriggs, D.; Poynor, E.; Chi, D.; Brown, C.; Barakat, R.; Danishefsky, S.; more...
    Annals of Oncology (1998)

    Fulltext@MSK | Save
  • Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer
    Journal Article

    Aghajanian, C.; Fennelly, D.; Shapiro, F.; Waltzman, R.; Almadrones, L.; O'Flaherty, C.; O'Conner, K.; Venkatraman, E.; Barakat, R.; Curtin, J.; more...
    Journal of Clinical Oncology (1998)

    Fulltext@MSK | Save
  • A phase II trial of intraperitoneal cisplatin and etoposide as consolidation therapy in patients with Stage II-IV epithelial ovarian cancer following negative surgical assessment
    Journal Article

    Barakat, R. R.; Almadrones, L.; Venkatraman, E. S.; Aghajanian, C.; Brown, C.; Shapiro, F.; Curtin, J. P.; Spriggs, D.
    Gynecologic Oncology (1998)

    Fulltext@MSK | Save
  • BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II)
    Journal Article

    Husain, A.; He, G.; Venkatraman, E. S.; Spriggs, D. R.
    Cancer Research (1998)

    Fulltext@MSK | Save